Evolutionary game theoretic strategy for optimal drug delivery to influence selection pressure in treatment of HIV-1

Cytotoxic T-lymphocyte (CTL) escape mutation is associated with long-term behaviors of human immunodeficiency virus type 1 (HIV-1). Recent studies indicate heterogeneous behaviors of reversible and conservative mutants while the selection pressure changes. The purpose of this study is to optimize the selection pressure to minimize the long-term virus load. The results can be used to assist in delivery of highly loaded cognate peptide-pulsed dendritic cells (DC) into lymph nodes that could change the selection pressure. This mechanism may be employed for controlled drug delivery. A mathematical model is proposed in this paper to describe the evolutionary dynamics involving viruses and T cells. We formulate the optimization problem into the framework of evolutionary game theory, and solve for the optimal control of the selection pressure as a neighborhood invader strategy. The strategy dynamics can be obtained to evolve the immune system to the best controlled state. The study may shed light on optimal design of HIV-1 therapy based on optimization of adaptive CTL immune response.

[1]  D. Richman,et al.  Rapid evolution of the neutralizing antibody response to HIV type 1 infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2]  L. Imhof,et al.  Stochasticity and evolutionary stability. , 2006, Physical review. E, Statistical, nonlinear, and soft matter physics.

[3]  Philippe Bousso,et al.  Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes , 2003, Nature Immunology.

[4]  P. Klenerman,et al.  Low level viral persistence after infection with LCMV: a quantitative insight through numerical bifurcation analysis. , 2001, Mathematical biosciences.

[5]  Alan S. Perelson,et al.  Dynamics of HIV Infection , 2003 .

[6]  D. Wodarz,et al.  Multiple Hiv-1 Infection of Cells and the Evolutionary Dynamics of Cytotoxic T Lymphocyte Escape Mutants , 2009, Evolution; international journal of organic evolution.

[7]  S. Self,et al.  On simulating strongly-interacting, stochastic population models. , 2004, Mathematical biosciences.

[8]  Todd M. Allen,et al.  HIV evolution: CTL escape mutation and reversion after transmission , 2004, Nature Medicine.

[9]  Avner Friedman,et al.  Modeling the immune rheostat of macrophages in the lung in response to infection , 2009, Proceedings of the National Academy of Sciences.

[10]  A. Chakraborty,et al.  T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation , 2008, Nature Immunology.

[11]  Wei Lu,et al.  Therapeutic dendritic-cell vaccine for chronic HIV-1 infection , 2004, Nature Medicine.

[12]  S. Henrickson,et al.  T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases , 2004, Nature.

[13]  W. Sundquist,et al.  Crucial for Viral Replication Virus Type 1 Core of Optimal Stability Is Formation of a Human Immunodeficiency , 2002 .

[14]  Rajat Varma,et al.  Peptide-MHC potency governs dynamic interactions between T cells and dendritic cells in lymph nodes , 2007, Nature Immunology.

[15]  Thomas L. Vincent,et al.  Evolutionary game theory: ESS, convergence stability, and NIS , 2009 .

[16]  F. Ronchese,et al.  CTLA-4 blockade during dendritic cell based booster vaccination influences dendritic cell survival and CTL expansion , 2007, Journal of immune based therapies and vaccines.

[17]  J. Spouge,et al.  Quantifying the infectivity of human immunodeficiency virus. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Garry,et al.  Both necrosis and apoptosis contribute to HIV-1-induced killing of CD4 cells. , 1999, AIDS.

[19]  B. Walker,et al.  Fitness Cost of Escape Mutations in p24 Gag in Association with Control of Human Immunodeficiency Virus Type 1 , 2006, Journal of Virology.

[20]  S. Self,et al.  On simulating strongly interacting, stochastic population models. II. Multiple compartments. , 2004, Mathematical biosciences.

[21]  G. Bocharov,et al.  Recombination: Multiply infected spleen cells in HIV patients , 2002, Nature.

[22]  A. Perelson,et al.  Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.

[23]  G. Shaw,et al.  Dynamics of HIV-1 recombination in its natural target cells , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Sleasman,et al.  HIV‐1 fitness and macrophages , 2003, Journal of leukocyte biology.

[25]  J. Routy,et al.  Arcelis AGS-004 dendritic cell-based immunotherapy for HIV infection. , 2010, Immunotherapy.

[26]  Q. Sattentau,et al.  Retroviral Spread by Induction of Virological Synapses , 2004, Traffic.

[27]  Mingjun Zhang,et al.  Immunodominance analysis through interactions of CD8+ T cells and DCs in lymph nodes. , 2010, Mathematical biosciences.

[28]  Alan S. Perelson,et al.  Mathematical Analysis of HIV-1 Dynamics in Vivo , 1999, SIAM Rev..

[29]  Jianbo Chen,et al.  Mechanisms of Nonrandom Human Immunodeficiency Virus Type 1 Infection and Double Infection: Preference in Virus Entry Is Important but Is Not the Sole Factor , 2005, Journal of Virology.

[30]  R. Germain,et al.  Dynamic Imaging of T Cell-Dendritic Cell Interactions in Lymph Nodes , 2002, Science.

[31]  Q. Sattentau,et al.  Avoiding the void: cell-to-cell spread of human viruses , 2008, Nature Reviews Microbiology.

[32]  Jianbo Chen,et al.  Nonrandom HIV-1 infection and double infection via direct and cell-mediated pathways. , 2004, Proceedings of the National Academy of Sciences of the United States of America.